108 related articles for article (PubMed ID: 16516855)
1. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
[TBL] [Abstract][Full Text] [Related]
2. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
[TBL] [Abstract][Full Text] [Related]
3. [Effect of nordy on FPR function of malignant human glioma cell line U87].
Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
[TBL] [Abstract][Full Text] [Related]
4. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
[TBL] [Abstract][Full Text] [Related]
5. Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.
Bian XW; Xu JP; Ping YF; Wang Y; Chen JH; Xu CP; Wu YZ; Wu J; Zhou XD; Chen YS; Shi JQ; Wang JM
Proteomics; 2008 Feb; 8(3):484-94. PubMed ID: 18232056
[TBL] [Abstract][Full Text] [Related]
6. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
[TBL] [Abstract][Full Text] [Related]
7. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Chen JH; Yao XH; Gong W; Hu J; Zhou XD; Chen K; Liu H; Ping YF; Wang JM; Bian XW
J Neurooncol; 2007 Sep; 84(3):223-31. PubMed ID: 17377739
[TBL] [Abstract][Full Text] [Related]
8. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
9. Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.
Xu CP; Zhang HR; Chen FL; Yao XH; Liang ZQ; Zhang R; Cui Y; Qian C; Bian XW
Int Immunopharmacol; 2010 Dec; 10(12):1602-7. PubMed ID: 20933627
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
11. Silencing the formylpeptide receptor FPR by short-interfering RNA.
Le Y; Iribarren P; Zhou Y; Gong W; Hu J; Zhang X; Wang JM
Mol Pharmacol; 2004 Oct; 66(4):1022-8. PubMed ID: 15258259
[TBL] [Abstract][Full Text] [Related]
12. The differentiation-inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8.
Zhao J; Zhao Y; Chen W; Li YM; Bian XW
Anticancer Drugs; 2008 Aug; 19(7):713-9. PubMed ID: 18594213
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds.
Zhang FJ; Yang JY; Mou YH; Sun BS; Ping YF; Wang JM; Bian XW; Wu CF
Chem Biol Interact; 2009 May; 179(2-3):419-29. PubMed ID: 19167369
[TBL] [Abstract][Full Text] [Related]
14. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
[TBL] [Abstract][Full Text] [Related]
15. [Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
Xu JP; Liu H; Bian XW; Chen JH; Zhou XD; Wu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):609-13. PubMed ID: 18070450
[TBL] [Abstract][Full Text] [Related]
16. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells.
Kam AY; Tse TT; Kwan DH; Wong YH
Cell Signal; 2007 Oct; 19(10):2106-17. PubMed ID: 17643960
[TBL] [Abstract][Full Text] [Related]
17. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
[TBL] [Abstract][Full Text] [Related]
18. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
Ping YF; Yao XH; Chen JH; Liu H; Chen DL; Zhou XD; Wang JM; Bian XW
J Neurooncol; 2007 Aug; 84(1):21-9. PubMed ID: 17415525
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
